Monsanto Company Company Profile (NYSE:MON)

About Monsanto Company

Monsanto Company logoMonsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity. Through its Seeds and Genomics segment, the Company produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds and precision agriculture to assist farmers in decision-making. It offers products, such as Germplasm and Biotechnology traits. Through its Agricultural Productivity segment, the Company manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: Agricultural Chemicals
  • Sub-Industry: Fertilizers & Agricultural Chemicals
  • Exchange: NYSE
  • Symbol: MON
  • CUSIP: 61166W10
Key Metrics:
  • Previous Close: $112.33
  • 50 Day Moving Average: $108.81
  • 200 Day Moving Average: $104.86
  • 52-Week Range: $83.73 - $114.26
  • Trailing P/E Ratio: 30.97
  • Foreward P/E Ratio: 20.96
  • P/E Growth: 2.97
  • Market Cap: $49.54B
  • Outstanding Shares: 438,554,000
  • Beta: 0.93
  • Net Margins: 11.61%
  • Return on Equity: 47.05%
  • Return on Assets: 10.66%
  • Debt-to-Equity Ratio: 1.82%
  • Current Ratio: 1.29%
  • Quick Ratio: 0.78%
Additional Links:
Companies Related to Monsanto Company:

Analyst Ratings

Consensus Ratings for Monsanto Company (NYSE:MON) (?)
Ratings Breakdown: 1 Sell Rating, 9 Hold Ratings, 15 Buy Ratings
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $114.84 (1.67% upside)

Analysts' Ratings History for Monsanto Company (NYSE:MON)
DateFirmActionRatingPrice TargetDetails
2/23/2017RBC Capital MarketsInitiated CoverageSector Perform$118.00View Rating Details
2/23/2017Royal Bank of CanadaInitiated CoverageSector Perform -> Sector Perform$118.00View Rating Details
1/6/2017CLSAUpgradeUnderperform -> OutperformView Rating Details
1/5/2017Sanford C. BernsteinSet Price TargetNeutral$105.00View Rating Details
11/18/2016OTR GlobalUpgradeNegative -> MixedView Rating Details
10/9/2016ArgusReiterated RatingBuy$128.00View Rating Details
10/8/2016BMO Capital MarketsReiterated RatingOutperform$128.00View Rating Details
10/6/2016J P Morgan Chase & CoSet Price TargetBuy$128.00View Rating Details
10/6/2016Deutsche Bank AGReiterated RatingBuyView Rating Details
10/6/2016Barclays PLCReiterated RatingHold$110.00View Rating Details
10/3/2016Monness Crespi & HardtLower Price TargetBuy$130.00 -> $128.00View Rating Details
9/27/2016Goldman Sachs Group, Inc. (The)UpgradeSell -> Neutral$104.00View Rating Details
9/15/2016Piper Jaffray CompaniesSet Price TargetBuy$128.00View Rating Details
9/15/2016S&P Equity ResearchReiterated RatingPositiveView Rating Details
9/6/2016Jefferies Group LLCReiterated RatingBuyView Rating Details
8/19/2016Citigroup Inc.Boost Price TargetNeutral$112.00 -> $116.00View Rating Details
5/27/2016Atlantic SecuritiesDowngradeOverweight -> Neutral$109.62 -> $105.00View Rating Details
5/25/2016MacquarieSet Price TargetBuy$110.00View Rating Details
5/24/2016Wells Fargo & CoReiterated RatingHoldView Rating Details
5/23/2016Vertical ResearchUpgradeHold -> BuyView Rating Details
5/13/2016Berenberg BankSet Price TargetBuy$110.00View Rating Details
4/12/2016Susquehanna Bancshares IncLower Price TargetPositive$105.00 -> $101.00View Rating Details
4/9/2016Morgan StanleyReiterated RatingBuyView Rating Details
4/7/2016Bank of America CorpReiterated RatingSell$88.00View Rating Details
3/3/2016Vertical GroupDowngradeBuy -> HoldView Rating Details
3/2/2016Credit Suisse GroupLower Price TargetOutperform$109.00 -> $97.00View Rating Details
10/9/2015Stifel NicolausLower Price TargetBuy$135.00 -> $115.00View Rating Details
8/24/2015Canaccord GenuityReiterated RatingBuy$134.00 -> $126.00View Rating Details
5/6/2015BB&T Co.Initiated CoverageHold -> HoldView Rating Details
(Data available from 2/25/2015 forward)


Earnings History for Monsanto Company (NYSE:MON)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/5/2017Q117$0.01$0.21$2.22 billionViewListenView Earnings Details
10/5/2016Q416($0.02)$0.07$2.38 billion$2.56 billionViewListenView Earnings Details
6/29/2016Q316$2.40$2.17$4.49 billion$4.19 billionViewListenView Earnings Details
4/6/2016Q216$2.44$2.42$4.81 billion$4.53 billionViewN/AView Earnings Details
1/6/2016Q116($0.22)($0.11)$2.41 billion$2.22 billionViewListenView Earnings Details
10/7/2015Q415($0.02)($0.19)$2.79 billion$2.36 billionViewListenView Earnings Details
6/24/2015Q315$2.06$2.39$4.58 billionViewListenView Earnings Details
4/1/2015Q215$2.93$2.90$5.58 billion$5.20 billionViewListenView Earnings Details
1/7/2015Q115$0.35$0.47$2.80 billion$2.87 billionViewListenView Earnings Details
10/8/2014Q414($0.23)($0.27)$2.41 billion$2.63 billionViewListenView Earnings Details
6/25/2014Q314$1.56$1.62$4.41 billion$4.25 billionViewListenView Earnings Details
4/2/2014Q214$3.08$3.15$5.81 billion$5.83 billionViewListenView Earnings Details
1/8/2014Q1$0.64$0.67$3.08 billion$3.15 billionViewListenView Earnings Details
10/2/2013Q413($0.43)($0.47)$2.24 billion$2.20 billionViewListenView Earnings Details
6/26/2013Q3 2013$1.59$1.66$4.41 billion$4.25 billionViewListenView Earnings Details
4/3/2013Q2 2013$2.58$2.73$5.29 billion$5.47 billionViewN/AView Earnings Details
1/8/2013Q1 2013$0.37$0.62$2.64 billion$2.93 billionViewListenView Earnings Details
10/3/2012Q412($0.43)($0.44)$2.25 billion$2.11 billionViewN/AView Earnings Details
6/27/2012$1.58$1.63ViewN/AView Earnings Details
4/4/2012$2.11$2.28ViewN/AView Earnings Details
1/5/2012$0.17$0.23ViewN/AView Earnings Details
10/5/2011($0.27)($0.22)ViewN/AView Earnings Details
4/6/2011$1.84$1.87ViewN/AView Earnings Details
1/6/2011$0.01$0.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Monsanto Company (NYSE:MON)
Current Year EPS Consensus Estimate: $4.73 EPS
Next Year EPS Consensus Estimate: $5.39 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$2.35$2.99$2.66
Q2 20163$2.29$2.73$2.50
Q3 20164($0.18)$0.15($0.02)
Q4 20162($0.08)$0.39$0.16
Q1 20172$0.04$3.57$1.81
Q2 20172$2.57$2.63$2.60
Q3 20171$1.77$1.77$1.77
Q4 20171$0.04$0.04$0.04
(Data provided by Zacks Investment Research)


Current Dividend Information for Monsanto Company (NYSE:MON)
Annual Dividend:$2.16
Dividend Yield:1.91%
Dividend Growth:11.60% (3 Year Average)
Payout Ratio:58.86% (Based on Trailing 12 Months of Earnings)
45.67% (Based on Current Year Consensus EPS Estimate)
40.07% (Based on Next Year Consensus EPS Estimate)
Track Record:7 Years of Consecutive Dividend Growth

Dividend History for Monsanto Company (NYSE:MON)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Monsanto Company (NYSE:MON)
Insider Ownership Percentage: 0.79%
Institutional Ownership Percentage: 75.18%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/25/2017Michael K SternCEOSell5,670$110.00$623,700.00View SEC Filing  
1/10/2017Steven MizellEVPSell2,525$108.56$274,114.00View SEC Filing  
11/17/2016Kerry J. PreeteEVPSell2,745$100.96$277,135.20View SEC Filing  
10/14/2016Robert T FraleyEVPSell80,631$102.04$8,227,587.24View SEC Filing  
10/10/2016Charles S McmillanDirectorBuy3,500$103.23$361,305.00View SEC Filing  
10/10/2016Steven MizellEVPSell310$103.09$31,957.90View SEC Filing  
7/14/2016Brett D BegemannCOOSell27,980$103.62$2,899,287.60View SEC Filing  
7/13/2016Michael K SternCEOSell12,797$101.77$1,302,350.69View SEC Filing  
4/19/2016George PosteDirectorSell1,136$91.93$104,432.48View SEC Filing  
4/14/2016Steven MizellEVPSell9,500$89.06$846,070.00View SEC Filing  
4/12/2016Charles S McmillanDirectorBuy3,500$87.25$305,375.00View SEC Filing  
4/12/2016Michael J FrankVPSell2,000$87.49$174,980.00View SEC Filing  
4/11/2016Steven MizellEVPSell3,900$86.87$338,793.00View SEC Filing  
11/17/2015Kerry J. PreeteEVPSell4,667$95.62$446,258.54View SEC Filing  
10/21/2015William U ParfetDirectorSell17,000$91.16$1,549,720.00View SEC Filing  
10/13/2015Steven MizellVPSell6,100$89.40$545,340.00View SEC Filing  
4/15/2015Kerry J PreeteEVPSell27,580$119.37$3,292,224.60View SEC Filing  
4/8/2015Tom D HartleyVPSell4,600$117.91$542,386.00View SEC Filing  
2/13/2015Michael K SternCOOSell1,391$125.00$173,875.00View SEC Filing  
1/20/2015David F SnivelyEVPSell29,521$117.14$3,458,089.94View SEC Filing  
1/12/2015Steven MizellVPSell20,500$118.72$2,433,760.00View SEC Filing  
11/17/2014Nicole M RingenbergVPSell12,780$118.83$1,518,647.40View SEC Filing  
10/15/2014Robert T FraleyEVPSell10,679$107.93$1,152,584.47View SEC Filing  
10/14/2014Nicole M RingenbergVPSell2,500$108.01$270,025.00View SEC Filing  
10/13/2014Steven MizellVPSell3,480$106.08$369,158.40View SEC Filing  
9/3/2014Kerry J PreeteEVPSell3,827$115.50$442,018.50View SEC Filing  
7/8/2014Michael J FrankVPSell7,500$124.53$933,975.00View SEC Filing  
7/7/2014Robert T FraleyEVPSell54,740$125.32$6,860,016.80View SEC Filing  
7/3/2014David F SnivelyEVPSell35,220$126.25$4,446,525.00View SEC Filing  
7/3/2014William U ParfetDirectorSell23,800$126.52$3,011,176.00View SEC Filing  
5/23/2014Janet M HollowaySVPSell21,280$120.00$2,553,600.00View SEC Filing  
5/7/2014Kerry PreeteEVPSell49,850$115.00$5,732,750.00View SEC Filing  
4/15/2014Hugh GrantCEOSell95,000$110.33$10,481,350.00View SEC Filing  
4/15/2014Tom HartleyVPSell7,900$110.51$873,029.00View SEC Filing  
1/17/2014Hugh GrantCEOSell44,179$112.69$4,978,531.51View SEC Filing  
1/16/2014Robert FraleyEVPSell64,850$112.57$7,300,164.50View SEC Filing  
1/14/2014Steven MizellVPSell24,000$112.05$2,689,200.00View SEC Filing  
11/11/2013Nicole RingenbergVPSell13,560$107.04$1,451,462.40View SEC Filing  
10/15/2013Tom HartleyVPSell5,860$105.70$619,402.00View SEC Filing  
10/8/2013Steven MizellVPSell11,370$104.50$1,188,165.00View SEC Filing  
10/7/2013Nicole RingenbergVPSell3,500$105.02$367,570.00View SEC Filing  
9/4/2013Kerry PreeteEVPSell5,276$99.00$522,324.00View SEC Filing  
7/19/2013Gerald A SteinerEVPSell12,293$104.00$1,278,472.00View SEC Filing  
7/9/2013Tom D HartleyVPSell6,000$100.15$600,900.00View SEC Filing  
7/8/2013Janet M HollowaySVPSell10,700$98.80$1,057,160.00View SEC Filing  
7/3/2013Hugh GrantCEOSell40,000$97.74$3,909,600.00View SEC Filing  
7/2/2013Steven MizellVPSell37,000$97.71$3,615,270.00View SEC Filing  
5/13/2013David F SnivelyEVPSell106,366$107.24$11,406,689.84View SEC Filing  
5/1/2013Pierre CourdurouxCFOSell5,720$105.47$603,288.40View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Monsanto Company (NYSE:MON)
DateHeadline logoStatus check: The latest on the $66B Bayer-Monsanto deal and what it means for RTP (NYSE:MON) - February 25 at 12:52 AM
News IconA Record Year for Bayer, Progress with Acquisition of Monsanto (NYSE:MON) - February 25 at 12:52 AM
News IconDo You Trust Snopes? You Won’t After Reading This. (NYSE:MON) - February 25 at 12:52 AM
News IconMonsanto Company (NYSE:MON) Equity Price Target Fixed At $118 - Transcript Daily (NYSE:MON) - February 24 at 7:51 PM
News IconBuy, Sell or Hold? Analysts Approach: Pioneer Natural Resources Company (PXD), Monsanto Company (MON)? - The USA Commerce (NYSE:MON) - February 24 at 7:51 PM
News IconABR Of Monsanto Company (NYSE:MON) At 1.7 - Stock Observer (NYSE:MON) - February 24 at 9:24 AM
News IconEarnings Guidance on Monsanto Company(MON) - Energy Index (NYSE:MON) - February 23 at 11:39 PM
News IconRevenue Approximations Analysis: Monsanto Company (MON), Harley-Davidson, Inc. (HOG) - StockNewsJournal (NYSE:MON) - February 23 at 11:39 PM logoBayer Details Financing Plan for Monsanto Deal - Wall Street Journal (subscription) (NYSE:MON) - February 23 at 11:39 PM
News IconMonsanto Company (MON) is Initiated by RBC Capital Mkts to “Sector Perform” - Highland Mirror (NYSE:MON) - February 23 at 11:39 PM
News IconBayer's hefty 2016 pharma growth underlines danger of neglecting R&D for Monsanto buy (NYSE:MON) - February 23 at 6:39 PM
News IconRare Footage Shows George Bush’s 1987 Visit To Monsanto, Uttering Seven Infamous Words That Would Change Everything (NYSE:MON) - February 23 at 6:38 PM logoCoverage initiated on Monsanto by RBC Capital Mkts (NYSE:MON) - February 23 at 6:38 PM logo10 Companies With the Worst Reputations (NYSE:MON) - February 23 at 6:38 PM
News IconAverage Brokerage Rating Of Monsanto Company (MON), Kimberly-Clark Corporation (KMB) - The USA Commerce (NYSE:MON) - February 23 at 8:14 AM
News IconChecking the Overall Picture for Monsanto Company (MON ... - StockNewsJournal (NYSE:MON) - February 23 at 8:14 AM
News IconBayer, confident about clinching Monsanto deal, hints at delays - Chicago Tribune (NYSE:MON) - February 23 at 8:14 AM logoBRIEF-Bayer confident it will receive CFIUS approval for Monsanto takeover (NYSE:MON) - February 22 at 11:47 PM
News IconMonsanto protesters win partial victory, but company to still grow corn in Marana (NYSE:MON) - February 22 at 11:47 PM logoAsian shares dip as Fed minutes show rate hike expected soon (NYSE:MON) - February 22 at 11:47 PM logoMonsanto: Analyst Recommendations, Price Target for February (NYSE:MON) - February 22 at 6:45 PM
News IconBayer confident of finalising Monsanto deal this year after winning Trump backing (NYSE:MON) - February 22 at 6:45 PM
News IconMonsanto Report Shows Company Made Substantial Progress Towards 2016 Sustainability Goals (NYSE:MON) - February 22 at 6:45 PM
News IconMonsanto withdraws from property tax break (NYSE:MON) - February 22 at 6:45 PM
News IconBayer plans to complete Monsanto takeover by end of year (NYSE:MON) - February 22 at 6:45 PM
News IconPima County strikes Monsanto tax deal incentive, company moves forward with site plan (NYSE:MON) - February 22 at 6:45 PM logoLocal agtech hub needs diversity, inclusion, leaders say (NYSE:MON) - February 22 at 6:45 PM logoBayer eyes $19B in equity to fund Monsanto deal before tapping bond market (NYSE:MON) - February 22 at 6:16 PM
News IconBayer, confident about clinching Monsanto deal, hints at delays - Pittsburgh Post-Gazette (NYSE:MON) - February 22 at 8:27 AM
News IconFortune 500 company Monsanto to grow GMO corn in Tucson - Cronkite News (NYSE:MON) - February 22 at 8:27 AM logoCovestro parent Bayer non-committal on any sale to industry peer (NYSE:MON) - February 22 at 8:27 AM
News IconWhy Investors remained confident on Nucor Corporation (NUE), Monsanto Company (MON)? - StockNewsJournal (NYSE:MON) - February 21 at 6:19 PM
News IconRandles and Splittgerber, LLP, Files Ten-State Class Action Lawsuit against Monsanto over Dicamba Devastation - Braymer Bee (NYSE:MON) - February 21 at 6:19 PM logoMonsanto Marks Substantial Progress against Sustainability Goals ... - Business Wire (press release) (NYSE:MON) - February 21 at 6:19 PM
News IconMajor Victory for California Cities vs. Monsanto Over PCB Contamination - EcoWatch (NYSE:MON) - February 20 at 5:58 PM
News IconOpponents 'More Determined Than Ever' to Keep Monsanto Out of Tucson - Arizona Public Media (NYSE:MON) - February 20 at 5:58 PM
News IconTrump Backing for Bayer's Monsanto Deal Buoys Investors (NYSE:MON) - February 20 at 10:04 AM
News IconAnti-Monsanto rally planned for Tuesday (NYSE:MON) - February 20 at 10:04 AM logoThe Wall Street Journal: Investors heartened by Trump’s apparent support of a Bayer-Monsanto merger (NYSE:MON) - February 20 at 8:45 AM
News IconMonsanto Faces Class-Action Suit Over Dicamba Damage (NYSE:MON) - February 19 at 5:41 PM
News IconMajor victory for California cities vs. Monsanto over PCB contamination (NYSE:MON) - February 19 at 5:41 PM
News IconMonsanto's AZ GMO Greenhouse (NYSE:MON) - February 19 at 5:41 PM
News IconLawsuit filed against Monsanto Company (NYSE:MON) - February 19 at 5:41 PM
News IconMonsanto responds to class action lawsuit involving Missouri farm, dicamba controversy (NYSE:MON) - February 19 at 9:52 AM
News IconFarmers in 10 States Sue Monsanto Over Dicamba Devastation (NYSE:MON) - February 19 at 9:52 AM logoMonsanto Again Named by Fortune Magazine as One of the World’s Most Admired Companies (NYSE:MON) - February 18 at 11:48 AM
News IconMonsanto Responds to Class Action Lawsuit Involving Missouri Farm (NYSE:MON) - February 18 at 11:48 AM
News IconMonsanto pulls Pima property-tax proposal, preserves trade-zone plan (NYSE:MON) - February 17 at 3:49 PM
News IconTen-state lawsuit against Monsanto filed (NYSE:MON) - February 17 at 3:49 PM
News IconGMOs at heart of Monsanto dispute (NYSE:MON) - February 17 at 3:49 PM


What is Monsanto Company's stock symbol?

Monsanto Company trades on the New York Stock Exchange (NYSE) under the ticker symbol "MON."

How often does Monsanto Company pay dividends? What is the dividend yield for Monsanto Company?

Monsanto Company announced a quarterly dividend on Friday, January 27th. Investors of record on Friday, April 7th will be paid a dividend of $0.54 per share on Friday, April 28th. This represents a $2.16 annualized dividend and a yield of 1.91%. The ex-dividend date is Wednesday, April 5th.

Where is Monsanto Company's stock going? Where will Monsanto Company's stock price be in 2017?

25 brokerages have issued twelve-month price objectives for Monsanto Company's stock. Their predictions range from $88.00 to $132.00. On average, they anticipate Monsanto Company's share price to reach $114.84 in the next twelve months.

When will Monsanto Company announce their earnings?

Monsanto Company is scheduled to release their next quarterly earnings announcement on Wednesday, April, 5th 2017.

What are analysts saying about Monsanto Company stock?

Here are some recent quotes from research analysts about Monsanto Company stock:

  • According to Zacks Investment Research, "Over the last one month, Monsanto’s shares outperformed the Zacks categorized Agricultural/Products industry. The company reported better-than-expected first-quarter fiscal 2017 earnings. Monsanto expects to close Bayer’s buyout deal by the fall of fiscal 2017. This would likely boost Monsanto’s competency within the industry. Moreover, rising global population, greater market penetration of products and new innovations are anticipated to reinforce near-term results. Over the last 30 days, Zacks Consensus Estimate for the stock has been revised upwards for both fiscal 2017 and 2018." (1/10/2017)

  • Goldman Sachs Group, Inc. (The) analysts commented, "The proposed deal now faces regulatory review, which MON believes should be benign due to limited product overlap with Bayer AG (ADR) (OTC: BAYRY). Nonetheless, investors appear to taking a wait and see approach as evidenced by a significant spread between today's closing price ($102) and the deal price ($128)," (9/27/2016)

  • Piper Jaffray Companies analysts commented, "We continue to believe that the potential opportunity to be acquired by Bayer is compelling, creating an entity that has all the key longer-term growth drivers," said Wong. Combination talks came during an increasingly competitive environment, applying pressures to Monsanto's core business according to the analyst. "A Bayer/Monsanto combination helps to ensure the new company will remain a leader among a changing ag backdrop with a more formidable competitor in Dow/DD and likely market disruption from the potential Syngenta/ChemChina combination," Wong added.Related Link: Bayer On Monsanto Bid: Push Toward Digital FarmingThe analyst said an offer would be in the low $140s per share and placed the target below $140 due to uncertainty on the deal.Wong was encouraged both companies would remain open to conversations in the future. The Jaffray analyst concluded, "Bayer will up the offer as long as the two companies are in discussions and Bayer is able to do further due diligence into the value that Monsanto provides." (6/13/2016)

Who owns Monsanto Company stock?

Monsanto Company's stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (4.54%), FMR LLC (2.99%), Davis Selected Advisers (1.34%), Franklin Resources Inc. (1.15%), Highfields Capital Management LP (0.84%) and Sands Capital Management LLC (0.83%). Company insiders that own Monsanto Company stock include Brett D Begemann, Charles S Mcmillan, George Poste, Kerry J Preete, Michael J Frank, Michael K Stern, Robert T Fraley, Steven Mizell, Tom D Hartley and William U Parfet.

Who sold Monsanto Company stock? Who is selling Monsanto Company stock?

Monsanto Company's stock was sold by a variety of institutional investors in the last quarter, including Sands Capital Management LLC, FMR LLC, Highland Capital Management LP, Davis Selected Advisers, Fred Alger Management Inc., I.G. Investment Management LTD., Putnam Investments LLC and Artemis Investment Management LLP. Company insiders that have sold Monsanto Company stock in the last year include Brett D Begemann, George Poste, Kerry J Preete, Michael J Frank, Michael K Stern, Robert T Fraley and Steven Mizell.

Who bought Monsanto Company stock? Who is buying Monsanto Company stock?

Monsanto Company's stock was acquired by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Renaissance Technologies LLC, State Street Corp, Asset Management One Co. Ltd., Manikay Partners LLC, Russell Investments Group Ltd., Westchester Capital Management LLC and Alpine Associates Management Inc..

How do I buy Monsanto Company stock?

Shares of Monsanto Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Monsanto Company stock cost?

One share of Monsanto Company stock can currently be purchased for approximately $112.96.

Monsanto Company (NYSE:MON) Chart for Saturday, February, 25, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Monsanto Company (NYSE:MON)

Earnings History Chart

Earnings by Quarter for Monsanto Company (NYSE:MON)

Dividend History Chart

Dividend Payments by Quarter for Monsanto Company (NYSE:MON)

Last Updated on 2/25/2017 by Staff